MIRA INFORM REPORT

 

 

Report Date :

20.04.2013

 

IDENTIFICATION DETAILS

 

Name :

ZHEJIANG MEDICINES & HEALTH PRODUCTS IMPORT & EXPORT CO., LTD.

 

 

Registered Office :

Zmc Building, No. 101-2, Zhongshan North Road, Hangzhou, Zhejiang Province 310003 Pr

 

 

Country :

China

 

 

Financials (as on) :

31.12.2011

 

 

Date of Incorporation :

29.06.1999

 

 

Com. Reg. No.:

330000000009213

 

 

Legal Form :

Limited Liabilities Company

 

 

Line of Business :

importing and exporting medical instruments.

 

 

No. of Employees :

320

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory 

 

 

Payment Behaviour :

No  Complaints 

 

 

Litigation :

Clear 

 

NOTES:

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – June 30th, 2012

 

Country Name

Previous Rating

(31.03.2012)

Current Rating

(30.06.2012)

China

A2

A2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 


 

china ECONOMIC OVERVIEW

 

Since the late 1970s China has moved from a closed, centrally planned system to a more market-oriented one that plays a major global role - in 2010 China became the world's largest exporter. Reforms began with the phasing out of collectivized agriculture, and expanded to include the gradual liberalization of prices, fiscal decentralization, increased autonomy for state enterprises, creation of a diversified banking system, development of stock markets, rapid growth of the private sector, and opening to foreign trade and investment. China has implemented reforms in a gradualist fashion. In recent years, China has renewed its support for state-owned enterprises in sectors it considers important to "economic security," explicitly looking to foster globally competitive national champions. After keeping its currency tightly linked to the US dollar for years, in July 2005 China revalued its currency by 2.1% against the US dollar and moved to an exchange rate system that references a basket of currencies. From mid 2005 to late 2008 cumulative appreciation of the renminbi against the US dollar was more than 20%, but the exchange rate remained virtually pegged to the dollar from the onset of the global financial crisis until June 2010, when Beijing allowed resumption of a gradual appreciation. The restructuring of the economy and resulting efficiency gains have contributed to a more than tenfold increase in GDP since 1978. Measured on a purchasing power parity (PPP) basis that adjusts for price differences, China in 2012 stood as the second-largest economy in the world after the US, having surpassed Japan in 2001. The dollar values of China's agricultural and industrial output each exceed those of the US; China is second to the US in the value of services it produces. Still, per capita income is below the world average. The Chinese government faces numerous economic challenges, including: (a) reducing its high domestic savings rate and correspondingly low domestic demand; (b) sustaining adequate job growth for tens of millions of migrants and new entrants to the work force; (c) reducing corruption and other economic crimes; and (d) containing environmental damage and social strife related to the economy's rapid transformation. Economic development has progressed further in coastal provinces than in the interior, and by 2011 more than 250 million migrant workers and their dependents had relocated to urban areas to find work. One consequence of population control policy is that China is now one of the most rapidly aging countries in the world. Deterioration in the environment - notably air pollution, soil erosion, and the steady fall of the water table, especially in the North - is another long-term problem. China continues to lose arable land because of erosion and economic development. The Chinese government is seeking to add energy production capacity from sources other than coal and oil, focusing on nuclear and alternative energy development. In 2010-11, China faced high inflation resulting largely from its credit-fueled stimulus program. Some tightening measures appear to have controlled inflation, but GDP growth consequently slowed to under 8% for 2012. An economic slowdown in Europe contributed to China's, and is expected to further drag Chinese growth in 2013. Debt overhang from the stimulus program, particularly among local governments, and a property price bubble challenge policy makers currently. The government's 12th Five-Year Plan, adopted in March 2011, emphasizes continued economic reforms and the need to increase domestic consumption in order to make the economy less dependent on exports in the future. However, China has made only marginal progress toward these rebalancing goals.

 

Source : CIA

 


Company name & address

 

ZHEJIANG MEDICINES & HEALTH PRODUCTS IMPORT & EXPORT CO., LTD.

ZMC BUILDING, NO. 101-2, ZHONGSHAN NORTH ROAD, HANGZHOU

ZHEJIANG PROVINCE 310003 PR CHINA

TEL: 86 (0) 571-87017661/87017663/28938381

FAX: 86 (0) 571-87016777/87792151

 

 

EXECUTIVE SUMMARY

 

Date of Registration          : JUNE 29, 1999

REGISTRATION NO.                  : 330000000009213

LEGAL FORM                           : Limited liabilities company

CHIEF EXECUTIVE                     : CHEN ZHANGSHENG (LEGAL REPRESENTATIVE)

REGISTERED CAPITAL             : cny 80,000,000

staff                                      : 320

BUSINESS CATEGORY             : TRADING

Revenue                                : CNY 3,503,054,000 (AS OF DEC. 31, 2011)

EQUITIES                                 : CNY 290,645,000 (AS OF DEC. 31, 2011)

WEBSITE                                 : www.zmchealthcare.com

E-MAIL                                     : wanglingli@zmcchina.com

PAYMENT                                : AVERAGE

MARKET CONDITION                : COMPETITIVE

FINANCIAL CONDITION             : stable

OPERATIONAL TREND              : STEADY

GENERAL REPUTATION           : AVERAGE

EXCHANGE RATE                     : CNY 6.18 = USD 1

 

Adopted abbreviations (as follows)

SC - Subject Company (the company inquired by you)

N/A – Not available

CNY – China Yuan Ren Min Bi

 

 

OPERATIONAL TREND & GENERAL REPUTATION

 

This section aims at indicating the relative positions of SC in respect of its operational trend & general reputation

 

Operational Trend:-                                             General Reputation:-

Upward                                                             Excellent

Steady                                                              Good

Fairly Steady                                                     Fairly Good

Ordinary                                                            Average

Fair                                                                   Fair

Stagnant                                                           Detrimental

Downward                                                         Not known

Not known                                                         Not yet be determined

LEGAL STATUS & HISTORY

 

SC was established as a limited liabilities company of PRC with State Administration of Industry & Commerce (SAIC) under registration No.: 330000000009213 on June 29, 1999.

 

SC’s Organization Code Certificate No.: 14291264-6

 

SC’s Tax No.: 330165142912646

 

SC’s registered capital: cny 80,000,000

 

SC’s paid-in capital: cny 80,000,000

 

Registration Change Record:-

 

Date

Change of Contents

Before the change

After the change

2000-06-19

Registered Capital

CNY 43,000,000

CNY 47,437,000

2002-01-21

Registered Capital

CNY 47,437,000

CNY 55,455,500

2002-07-10

Registered Capital

CNY 55,455,500

CNY 61,069,375

2003-07-18

Registered Capital

CNY 61,069,375

CNY 65,000,000

2004-08-04

Registered Capital

CNY 65,000,000

CNY 69,000,000

2005-09-05

Registered Capital

CNY 69,000,000

CNY 40,000,000

2006-08-10

Registered Capital

CNY 40,000,000

CNY 56,000,000

2007-09-17

Registered Capital

CNY 56,000,000

CNY 63,000,000

2007-10-11

Registration No.

3300001005837

442000000384289

2009-08-26

Registered Capital

CNY 63,000,000

CNY 70,000,000

2010-04-06

Legal Representative

Li Fusheng

Chen Zhangsheng

2011

Registered Capital

CNY 70,000,000

cny 80,000,000

 

Current Co search indicates SC’s shareholders & chief executives are as follows:-

Name of Shareholder (s)

% of Shareholding

Zhejiang International Business Group Co., Ltd.

 

33.50

Employee Shareholders Association

 

47.72

Bai Minzi

 

1.17

Chen Zhangsheng

 

1.13

Li Lin

 

1.07

Wang Ping

 

1.07

Other 33 individuals

 

14.34

 

SC’s Chief Executives:-

 

Position

Name

Legal Representative, Chairman, and General Manager

Chen Zhangsheng

Director

Li Lin

Wang Baoping

Liu Junguang

Huang Hai

Supervisor

Wang Ping

Gong Yougen

Xie Weiran

 

 

RECENT DEVELOPMENT

 

SC obtained GSP Certificate, ISO Certificate and JAS Certificate.

 

 

 

SHAREHOLDER CHART & BACKGROUND

 

Name                                                                                      % of Shareholding

 

Zhejiang International Business Group Co., Ltd.                            33.50

 

Employee Shareholders Association                                                                    47.72

Bai Minzi                                                                                                           1.17

Chen Zhangsheng                                                                                              1.13

Li Lin                                                                                                                1.07

Wang Ping                                                                                                        1.07

Other 33 individuals                                                                                            14.34

 

n         Zhejiang International Business Group Co., Ltd.

---------------------------------------------------------------

Zhejiang International Business Group Co., Ltd. was establishes in 2008. It is a sole state-owned enterprise invested by the provincial government. The registered capital of the group is 980 million Yuan, which comes from the capital of original Rongda Group, Zhongda Group, and Dongfang Group. The legal residence of the group is 199 Qingchun Road, Hangzhou City, Zhejiang. Conduct scope covers all the ranging in the authorization scope. It involve foreign trading, economy cooperation, real estate, industry investment, trade service, financial stock, and the import and export trade is the main business. The group built up extensive and stable trade cooperative relationship with the well-know companies from 213 nations and region. The group exports more than 210 series of products, mainly including textile products, clothing, primary product, medical and chemical products, light industry article, machinery and electricity product, and set equipments, etc.

Legal Representative: Wang Tingge

Registration No.: 330000000018008

Tel: 86 (0) 571-87385921

Fax: 86 (0) 571-87385988

E-mail: info@zibchina.com

Website: www.zibchina.com

 

 

MANAGEMENT

 

Chen Zhangsheng, Legal Representative, Chairman and General Manager

------------------------------------------------------------------------------------------------------------

Ø         Gender: M

Ø         Age: 56

Ø         ID# 330105195610290313

Ø         Qualification: University

Ø         Working experience (s):

 

From 1999 to April of 2010, worked in SC as vice chairman and general manager

From April of 2010 to present, working in SC as legal representative, chairman and general manager

 

 

Director

-----------

Li Lin                ID# 330102195210010336

Wang Baoping   ID# 610104196309090115

Liu Junguang     ID# 33010219540320003X

Huang Hai         ID# 330103196312161339

 


Supervisor

-------------

Wang Ping        ID# 330103195606170025

Gong Yougen    ID# 330106196211301565

Xie Weiran         ID# 330106196504100134

 

 

BUSINESS OPERATION

 

SC’s registered business scopes include operating medical machinery (validity period as of Jun. 14, 2014; selling Chinese traditional medicinal crops, Chinese patent medicines, traditional Chinese medicines prepared in ready-to-use forms, chemical raw materials, chemical agent, antibiotic, biochemical, acetic anhydride, and phenyl acetic acid; selling dangerous chemical products; operating non-medicine poisonous chemicals (validity period as of Oct. 11, 2012), and potassium permanganate; importing and exporting business.

 

SC is mainly engaged in importing and exporting medical instruments.

 

SC’s products mainly include: medical instruments, pharmaceuticals & intermediates, natural plant extracts & food additives, medicines & preparations, etc.

 

SC sources its materials 70% from domestic market, and 30% from U.S.A. and Europe. SC sells 30% of its products in domestic market, and 70% to Asian, Europe, America, etc.

 

The buying terms of SC include Check, T/T, L/C and Credit of 30-60 days. The payment terms of SC include Check, T/T, L/C and Credit of 30-60 days.

 

*Major Customers:

==============

Divatex Home Fashions Inc.

Better Brake Parts Inc.

A&S International Inc.

 

Staff & Office:

--------------------------

SC is known to have approx. 320 staff at present.

 

SC owns an area as its operating office of approx. 2,000 sq. meters at the heading address.

 

 

RELATED COMPANY

 

SC is known to invest in the following companies:

 

·         Zhejiang Yibao Health Products Co., Ltd.

Zhejiang International Business Group Logistics Co., Ltd.

Zhejiang Shangshang Medicine and Health Products Co., Ltd.

Ningbo Huana Chemical Co., Ltd.

Jiangsu Meinuo Medical Instrument Co., Ltd.

Quzhou Chemsyn Pharm. Co., Ltd.

Shandong Liyuan Pharmaceutical Co., Ltd.

Zhejiang Hisun Chemical Co., Ltd.

Pinghu Xinjiyuan Raiment Co., Ltd.

Etc.

 

PAYMENT

 

Overall payment appraisal:

( ) Excellent      ( ) Good      (X) Average      ( ) Fair      ( ) Poor      ( ) Not yet be determined

The appraisal serves as a reference to reveal SC's payments habits and ability to pay.  It is based on the 3 weighed factors: Trade payment experience (through current enquiry with SC's suppliers), our delinquent payment and our debt collection record concerning SC.

 

Trade payment experience: SC did not provide any name of trade/service suppliers and we have no other sources to conduct the enquiry at present.

 

Delinquent payment record: None in our database.

 

Debt collection record: No overdue amount owed by SC was placed to us for collection within the last 6 years.

 

 

BANKING

 

Basic Bank:

 

Bank of China Zhejiang Branch

AC#: 800100024308091001

 

 

fINANCIALS

 

Balance Sheet

Unit: CNY’000

As of Dec. 31, 2010

As of Dec. 31, 2011

Cash

57,070

32,713

Notes receivable

0

2,050

Accounts receivable

321,441

424,112

Advances to suppliers

89,207

91,925

Other receivable

121,055

95,181

Inventory

171,857

182,118

Non-current assets within one year

0

0

Other current assets

4,947

5,244

 

------------------

------------------

Current assets

765,577

833,343

Fixed assets

19,591

16,863

Construction in progress

9,256

9,256

Intangible assets

0

0

Long-term prepaid expenses

337

1,012

Deferred income tax assets

5,537

7,533

Other non-current assets

76,978

87,145

 

------------------

------------------

Total assets

877,276

955,152

 

=============

=============

Short-term loans

27,159

148,386

Notes payable

380,074

237,219

Accounts payable

62,794

102,949

Wages payable

14,401

14,451

Taxes payable

-16,241

-15,977

Advances from clients

155,551

166,338

Other payable

20,561

11,141

Other current liabilities

0

0

 

------------------

------------------

Current liabilities

644,299

664,507

Non-current liabilities

93

0

 

------------------

------------------

Total liabilities

644,392

664,507

Equities

232,884

290,645

 

------------------

------------------

Total liabilities & equities

877,276

955,152

 

Income Statement

Unit: CNY’000

As of Dec. 31, 2010

As of Dec. 31, 2011

Revenue

3,441,598

3,503,054

     Cost of sales

3,261,392

3,330,007

     Taxes and surcharges

1,167

959

     Sales expense

67,335

71,892

     Management expense

44,677

54,759

     Finance expense

-22,491

-56,586

Non-business income

3,877

4,815

     Non-business expenditure

4,096

1,450

Profit before tax

90,649

102,612

Less: profit tax

22,862

25,088

Profits

67,787

77,524

 

Important Ratios

=============

 

As of Dec. 31, 2010

As of Dec. 31, 2011

*Current ratio

1.19

1.25

*Quick ratio

0.92

0.98

*Liabilities to assets

0.73

0.70

*Net profit margin (%)

1.97

2.21

*Return on total assets (%)

7.73

8.12

*Inventory / Revenue ×365

19 days

19 days

*Accounts receivable/ Revenue ×365

35 days

45 days

* Revenue/Total assets

3.92

3.67

* Cost of sales / Revenue

0.95

0.95

 

 

FINANCIAL COMMENTS

 

PROFITABILITY: AVERAGE

l         The revenue of SC appears fairly good, and it was rising in 2011.

l         SC’s net profit margin is average in both years.

l         SC’s return on total assets is fairly good in both years.

l         SC’s cost of sales is fairly high, comparing with its revenue.

 

LIQUIDITY: AVERAGE

l         The current ratio of SC is maintained in a normal level.

l         SC’s quick ratio is maintained in a normal level.

l         The inventory of SC appears average.

l         The accounts receivable of SC is maintained in an average level.

l         SC’s short-term loans are in an average level.

l         SC’s revenue is in a fairly good level, comparing with the size of its total assets.

 

LEVERAGE: FAIRLY GOOD

l         The debt ratio of SC is average.

l         The risk for SC to go bankrupt is low.

 

Overall financial condition of the SC: Stable.

 

 

CONCLUSIONS

 

SC is considered medium-sized in its line with stable financial conditions.


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.54.03

UK Pound

1

Rs.82.43

Euro

1

Rs.70.49

 

INFORMATION DETAILS

 

Report Prepared by :

MNL

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

----

NB

New Business

----

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.